A prospective open label, multicenter phase 2 trial of full-dose gemcitabine and S-1 concurrent with radiation for locally advanced pancreatic ductal adenocarcinoma (BR + UR-LA) (CSGO-HBP-008).
- DOI
- 10.1007/s00595-026-03481-z
- Published
- 2026 Sep 4
- Container
- Surgery today
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s00595-026-03481-z,
title = {A prospective open label, multicenter phase 2 trial of full-dose gemcitabine and S-1 concurrent with radiation for locally advanced pancreatic ductal adenocarcinoma (BR + UR-LA) (CSGO-HBP-008).},
author = {Katsura Y and Kobayashi S and Takeda Y and Ohmura Y and Takahashi H and Asaoka T and Iwagami Y and Nakahira S and Shimizu J and Doki Y and Eguchi H},
year = {2026},
journal = {Surgery today},
doi = {10.1007/s00595-026-03481-z},
url = {https://doi.org/10.1007/s00595-026-03481-z}
}RIS
TY - JOUR TI - A prospective open label, multicenter phase 2 trial of full-dose gemcitabine and S-1 concurrent with radiation for locally advanced pancreatic ductal adenocarcinoma (BR + UR-LA) (CSGO-HBP-008). AU - Katsura Y AU - Kobayashi S AU - Takeda Y AU - Ohmura Y AU - Takahashi H AU - Asaoka T AU - Iwagami Y AU - Nakahira S AU - Shimizu J AU - Doki Y AU - Eguchi H PY - 2026 JO - Surgery today DO - 10.1007/s00595-026-03481-z UR - https://doi.org/10.1007/s00595-026-03481-z ER -
APA
Y, K., S, K., Y, T., Y, O., H, T., T, A., Y, I., S, N., J, S., Y, D., & H, E. (2026). A prospective open label, multicenter phase 2 trial of full-dose gemcitabine and S-1 concurrent with radiation for locally advanced pancreatic ductal adenocarcinoma (BR + UR-LA) (CSGO-HBP-008).. Surgery today. https://doi.org/10.1007/s00595-026-03481-z
Source records
- pubmed · retrieved 2026-09-25T13:47:09.912Z
- europe-pmc · retrieved 2026-09-25T13:47:09.926Z